https://www.taxtmi.com/news?id=31707 An AI-enhanced in-vitro chemosensitivity assay produces time-lapse video and automated quantification of tumour cell responses to chemotherapy, reporting on standard-of-care and off-label drug options for solid organ tumours; the platform is presented as clinically validated and deployed from facilities accredited under CAP and CLIA, emphasizing human-supervised AI analysis and provision of verifiable visual evidence to inform clinician treatment selection. en-us Tue, 28 Jan 2025 15:31:02 +0530 Tue, 28 Jan 2025 15:31:02 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=31707 An AI-enhanced in-vitro chemosensitivity assay produces time-lapse video and automated quantification of tumour cell responses to chemotherapy, reporting on standard-of-care and off-label drug options for solid organ tumours; the platform is presented as clinically validated and deployed from facilities accredited under CAP and CLIA, emphasizing human-supervised AI analysis and provision of verifiable visual evidence to inform clinician treatment selection. News - Tue, 28 Jan 2025 15:31:02 +0530 https://www.taxtmi.com/news?id=31707